MedPath

Maastricht University

Maastricht University logo
🇳🇱Netherlands
Ownership
Private
Established
1976-01-01
Employees
5K
Market Cap
-
Website
http://www.maastrichtuniversity.nl

Radiomics in Rectal Cancer: A Powerful Tool for Diagnosis, Treatment Response Evaluation, and Prognosis Prediction

• Radiomics, an advanced computational approach that extracts quantitative features from medical images, is revolutionizing rectal cancer management by providing more accurate tumor staging and treatment response prediction than conventional imaging methods. • Recent studies demonstrate radiomics' effectiveness in predicting lymph node metastasis, distant metastasis, and pathological complete response to neoadjuvant therapy, with multimodal approaches combining CT, MRI, and ultrasound showing the highest predictive accuracy. • The integration of radiomics with deep learning algorithms and molecular markers represents the future direction of research, potentially enabling more personalized treatment strategies and improved patient outcomes in rectal cancer care.
© Copyright 2025. All Rights Reserved by MedPath